Back

Intermittent hypoxic-hyperoxic exposure in patients with heart failure – a pilot study

28 August 2026 (09:15 - 10:00)
Organised by: Logo
Congress Presentation Part of: Challenges in optimising heart failure therapy Rehabilitation ESC2026 Premium Access ESC Congress 2026 European Society of Cardiology

About the speaker

Photo
Associate Professor Tarek Bekfani

University hospital Magdeburg A.o.R., Magdeburg (Germany)

6 More presentations in this session

Presentation thumbnail
Factors associated with oral SGLT2 inhibitor use and prognosis in elderly heart failure patients
Doctor R. Nakano-Kurimoto (Kyoto, JP)
Abstract Slides Video
Presentation thumbnail
Renin-angiotensin system inhibition and survival in elderly HFrEF with CKD: a target trial emulation
Doctor P. Puiu (Zurich, CH)
Abstract Slides Video
Presentation thumbnail
Cardiovascular outcomes with potassium binders in patients with heart failure and hyperkalemia
Professor L. Fauchier (Tours, FR)
Abstract Slides Video
Presentation thumbnail
Safety of potassium-binding agents in HFrEF: a meta-analysis of randomized trials
Doctor T. Carlos (Coimbra, PT)
Abstract Slides Video
Presentation thumbnail
Assessment of venous congestion in HFrEF using VExUS in a cohort of patients treated with Vericiguat
Doctor F. Ferranti (Rome, IT)
Abstract Slides Video

Access the full session

Session thumbnail
Challenges in optimising heart failure therapy

The Event

Event poster

ESC Congress 2026

28 August 2026 09:15 CET
You may be interested in
thumbnail
Congress Presentation
REDOX-AHF: Restrictive versus liberal oxygenation targets in acute heart failure
9 May 2026
thumbnail
Congress Presentation
THe Sub-Saharan Africa Survey of Heart Failure (THESUS-HF II): Aetiology, 30- days and 6 months outcome
28 August 2026
thumbnail
Congress Presentation
Multi-omics profiling identifies inflammation metabolism fibrosis crosstalk as a defining feature of HFpEF distinct from HFrEF
28 August 2026
thumbnail
Congress Presentation
In-hospital treatment intensification and outcomes in patients hospitalised for worsening heart failure in the current era of guideline-directed medical treatment
28 August 2026

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources